Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

STERIS AST provides contract sterilization, laboratory testing, and product and packaging testing services to medical device and pharmaceutical manufacturers.

STERIS AST

Quest Diagnostics provides diagnostic testing services, including in-home sample collection and personalized care.

Quest Diagnostics

Quest Diagnostics Women’s Health

QuestQuanum

Quest for Health Systems 

Quest Diagnostics HTAS India

Quest for Community Health

Quest Healthcare Analytics Solutions

Quest Diagnostics BioPharma Services

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.  Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. 

Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. 

Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. 

Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. 

The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals.

More information is available at www.questdiagnostics.com.

Language Assistance / Non-Discrimination Notice
Asistencia de Idiomas / Aviso de no Discriminación
語言協助 / 不歧視通知
www.QuestDiagnostics.com/home/nondiscrimination

Lemonaid Health

SomaLogic

During this year’s National Health Center Week, we are honored to celebrate the diligent, committed work of nearly 285,000 staff and volunteers across our country. They’re innovators, healers, and problem solvers who are all deeply dedicated to the Community Health Center mission of providing high-quality healthcare services to everyone, regardless of insurance status or income. 

#NHCW24 #ValueCHCs #CommunityHealth #QuestDiagnostics

Community Health Centers serve 1 in 11 people in the US, including:

•	1 in 9 children and adolescents
•	1 in 4 racial and ethnic minorities
•	1 in 6 Medicaid beneficiaries
•	1 in 5 uninsured persons
•	1 in 3 people in poverty

For over 50 years, health centers have been dedicated to making quality, affordable healthcare available to everyone in their communities, regardless of ability to pay or insurance stats.

We celebrate health center patients this National Health Center Week and always! 

#NHCW24 #ValueCHCs #CommunityHealth #QuestDiagnostics

We're proud to celebrate National Health Center Week 2024 taking place August 4-10. The annual event highlights the essential role that Community Health Centers play in improving public health and advancing health equity. For over 50 years, Community Health Centers have provided high-quality, affordable, comprehensive primary and preventive healthcare in our nation’s medically underserved communities, delivering value to and having a significant impact on America’s healthcare system. 

#NHCW24 #ValueCHCs #CommunityHealth #QuestDiagnostics

Bread of Life Academy, a program under nonprofit Bread of Life, Inc.—a Quest for Health Equity (Q4HE) grantee—recently held a graduation ceremony to celebrate a graduating class of 40 students pursuing careers as phlebotomists and community health workers (CHWs).

The Bread of Life Academy provides educational opportunities for marginalized and under-resourced individuals in the Houston area, equipping them with essential skills to enhance their employability in the healthcare sector while also addressing critical shortages in allied health professions. The program focuses on training and certifying students as CHWs and phlebotomists.

Congrats to the graduates!

You can read more about Bread of Life Academy and our work with BOL here: http://spr.ly/6044cqUHo

#Q4HE #Graduation #HealthEquity

Due to the global information outage that occurred this morning, Quest is taking swift action to respond, recover and restore our operations. Our Patient Services and Customer Contact teams are operating with reduced capacity, so you may experience longer wait and service times. We appreciate your patience as we work toward returning to normal operations.

We have restored nearly all systems affected by the global information outage, and welcome patients to visit our Patient Service Centers. To reschedule a missed appointment, please visit our online scheduling site: https://lnkd.in/etBcu-eY

Metric
Company Name	Quest Diagnostics Incorporated	STERIS AST
Symbol	DGX
MSH ID	COM:QUESTDIAGNOSTICS	COM:STERIS-AST
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Diagnostics & Research	Medical Device and Pharmaceutical Services
Country	US	US
Stage
Employee Count	50K
Website	questdiagnostics.com	steris-ast.com
LinkedIn	quest-diagnostics
Founders

Metric
Market Cap	15.60B
Enterprise Value
Monthly Web Traffic	17.21M
Web Traffic Growth	0.14
Valuation
Raised Capital	1.85B

Metric
Revenue	9.25B
Revenue (LTM)
Revenue (NTM)
Gross Profit	3.05B
EBITDA	1.26B
Operating Income	1.26B
Net Income	854M
EPS	7.63
Diluted EPS	7.56
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.33
Operating Profit Margin	0.14
EBITDA Margin	0.14
Net Profit Margin	0.09
Return on Equity	0.14
Return on Assets	0.06
Return on Capital Employed	0.11

COM:QUESTDIAGNOSTICS

Quest Diagnostics

Last Close

163.89

22/11 21:00

Market Cap

15.60B

Beta: -

Volume Today

596.44K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	16.23
P/B Ratio	2.20
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.87
EV Multiple	7.06

Metric
Days Sales Outstanding	47.74
Days Payables Outstanding
Days Inventory Outstanding	11.19
Operating Cycle	62.53
Cash Conversion Cycle	62.07
Asset Turnover	0.67

Metric
Operating Cash Flow	1.27B
Free Cash Flow	864M
Cash Flow to Debt	0.27
Operating Cash Flow/Sales	0.14
Free Cash Flow Yield	0.04

Metric
Cash & Equivalents	686M
Accounts Receivable	-15M
Inventory	190M
Goodwill	7.73B
Debt to Capitalization	0.44
Debt to Assets	0.38
Current Ratio	1.31
Quick Ratio	1.04

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue
SG&A to Revenue